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Abstract
Six new polyisoprenyl benzophenonoids, (±)-garcinialiptone A (1, 2), garcinialiptone B (3), (−)-
cycloxanthochymol (4), garcinialiptone C (5), and garcinialiptone D (6), along with three known
compounds, xanthochymol (7), isoxanthochymol (8), and cycloxanthochymol (9), were isolated
from the fruits of Garcinia subelliptica. The structures of 1–6 were elucidated by spectroscopic
analysis. Biological evaluation showed that all compounds 1–9 exhibited cytotoxic activity against
a small panel of human tumor cell lines (A549, DU145, KB, vincristine-resistant KB).
Garcinia subelliptica Merr. (Guttiferae) is a tree that serves as a dye source in tropical and
subtropical Asia. Several xanthones and phloroglucinol derivatives have been isolated from
this plant,1–14 and found to exhibit various biological activities, including inhibitory activity
against DNA topoisomerases I and II,13 and antioxidant,2 anti-inflammatory,9, 10 and
cytotoxic12 effects. Polyisoprenylated benzophenones isolated from the Guttiferae family
feature a bicyclo[3.3.1]-nonane-2,4,9-trione skeleton substituted with a benzoyl group and
prenyl or geranyl groups. These polyprenylated benzoylphloroglucinol derivatives are
classified into three types according to the relative position of the benzoyl group.16 Type A,
with the benzoyl group linked at C-1, is exemplified by nemorosone16 and garcinielliptone
FB;12 type B, with the benzoyl group at C-3, is represented by xanthochymol, the main
component of G. subelliptica; and type C, with the benzoyl group at C-5, is typified by
garcinielliptone K.11 Many polycyclic polyprenylated acylphloroglucinol derivatives, also
isolated from plants of the family Guttiferae, undergo secondary cyclizations involving the
β-diketone and olefinic groups to afford admantanes, homoadamantanes, dihydrofuro-fused
structures, and related structures.17 The occurrence of cyclized secondary metabolites is also
documented for polyprenylated benzoylphloroglucinol derivatives.
In a continuing search for novel plant-derived antitumor agents, it was found that an acetone
extract of the fruits of G. subelliptica showed moderate cytotoxicity against Hela and WiDr
cells. Bioassay-directed fractionation of G. subelliptica resulted in the isolation of six new
cytotoxic polyisoprenyl benzophenonoids, (±)-garcinialiptone A (1, 2, type B),
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garcinialiptone B (3, type C), (−)-cycloxanthochymol (4, type B), garcinialiptone C (5, type
A), and garcinialiptone D (6, type A), along with three known compounds xanthochymol (7,
type B), isoxanthochymol (8, type B), and cycloxanthochymol (9, type B).
Results and Discussion
Extraction of the fruits of G. subelliptica with acetone, followed by chromatography, led to
the isolation of nine compounds, including the known compounds 7–9, as well as six new
polyprenylated benzoylphloroglucinol compounds (1–6).
Compounds 1 and 2 [the (+) and (−) isomers of garcinialiptone A], obtained as yellow
amorphous solids, had almost identical HRESIMS, UV, IR, and NMR spectra. Compound 1
was assigned the molecular formula C38H48O6 (corresponding to 15 degrees of
unsaturation) on the basis of positive-ion HRESIMS of the peak at m/z 623.3377 [M + Na]+.
Signals for hydroxy (3403 cm−1), carbonyl (1742, 1700 cm−1), and aromatic (1599, 1549,
1440 cm−1) groups were found in the IR spectrum of 1, and its UV spectrum showed peak
maxima at 314, 280, and 232 nm. The molecular formula, together with NMR evidence
(Table 1 and Table 2), indicated that 1 has a tri-oxygenated benzophenone-derived skeleton.
Based on 13C NMR signals at δ 203.9, 202.4 and 202.0 ppm,18 the tri-oxygenated ring is
non-aromatic and has three nonconjugated ketones. In addition to a pendant di-oxygenated
benzoyl group, the NMR data supported the presence of five additional five-carbon units: a
2-isopropenyl-5-methylhex-5-enyl group made up of two 3-methyl-3-butenyl units with one
(C-22 to C-26) linked to the C-2 (C-18) position of the other (C-17 to C-21), two individual
3-methyl-2-butenyl groups (C-27 to C-31 and C-34 to C-38), and gem-dimethyl groups
(C-32 and C-33) attached to a quaternary center (C-8), in turn attached to a methine (C-7)
and methylene (C-6). The foregoing data account for 12 of the 15 required degrees of
unsaturation. The absence of additional signals for sp2 carbons suggested that 1 contains a
tricyclic moiety. Its structure and the location of the attached groups were fully determined
from 1H-1H COSY, HSQC and HMBC data (Figure 1).
In the 1H-1H COSY spectrum, cross peaks were found between H-34/H-35 and H-7, and
between H-6/H-7. Moreover, in the HMBC spectrum, long-range correlations were observed
between H-34/C-3 (δC 79.7), C-4 (δC 202.0), C-6 (δC 44.4), and C-7 (δC 47.6), and between
H-7/C-1 (δC 77.1), C-3, and C-5 (δC 68.6). These facts indicated that the methine carbon
(C-34) was connected to three carbons (C-35, C-7, and C-3). Furthermore, long-range
correlations between H2-27 (δH 2.68, dd, J = 13.5, 6.5 Hz and 2.53, dd, J = 13.5, 6.0 Hz)/
C-1, C-2, and C-9 showed that one 3-methyl-2-butenyl unit was located at C-1, while
correlations between H2-17 (δH 2.17, dd, J = 14.0, 9.0 Hz and 1.95, m)/C-9 (δC 203.9), C-4,
C-5, and C-6 permitted the assignment of the 2-isopropenyl-hex-5-enyl group at C-5. The
linkages from C-1 to C-8 to C-7 were determined based on 3J HMBC correlations between
the gem-dimethyl groups (δH 1.11 and 1.12, each 3H, s) at C-8 with C-1 and C-7. Also,
based on 2J and 3J HMBC correlations (Figure 1), the 3,4-dihydroxybenzoyl group was
attached at C-3 of the main skeleton. Thus, the main tricyclic core skeleton of 1 and
locations of the pendant residues were established as shown.
Regarding the relative configuration at H-34, this proton showed W-coupling in the 1H
NMR spectrum to H-6, a strong HMBC cross peak with C-4, and a weak peak with C-2,
together with a NOE interaction with the C-33 methyl protons, indicating an anti-
arrangement of C-4 and H-34. Thus, the stereochemistry of H-34 was determined, and was
also consistent with a literature report for plukenetione A.18
Compound 1 and hyperibone K19 gave similar 1H and 13C NMR spectra, except for signals
for 2-isopropenyl-hex-5-enyl and 3,4-dihydroxybenzoyl groups in the former rather than a
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prenyl moiety and unsubstituted benzoyl group in the latter. The specific optical rotation
[α]25D + 12.1 (c 3.40, MeOH) of 1 was similar to those of hyperibone K19 [+22.3 (c 0.3,
CHCl3)] and plukenetione A18 [+1 (c 0.77, CHCl3)]. As a result of this supporting
information, the structure of 1 was deduced completely, and 1 is an analog of hyperibone K
and plukenetione A.
Although 1 and 2 have very similar UV, IR, and NMR data, as well as the same molecular
ion in HRESIMS, they were found to have opposite optical rotations. The specific rotation
of 2 was −17.3 (c 3.36, MeOH). These findings verified that 1 and 2 are enantiomers. Thus,
1 and 2 have been named (+)-garcinialiptone A and (−)-garcinialiptone A, respectively.
Garcinialiptone B (3) was isolated as an optically active yellow amorphous solid, [α]25D
+84.8 (c 5.40, MeOH). The molecular formula was established as C38H48O6 from the
HRESIMS (m/z 623.3386 [M + Na]+). The IR spectrum of 3 displayed bands for hydroxy
(3300 cm−1), carbonyl (1726, 1670, 1640 cm−1), and aromatic (1594, 1519, 1439 cm−1)
groups. Although 1–3 have the same molecular formula and, thus, degrees of unsaturation,
the 1H and 13C NMR data of 3 (Table 1 and Table 2) indicated a structural variation from
the caged structures of 1 and 2. The 13C NMR spectrum of 3 (Table 2) showed resonances
for six aromatic carbons, a conjugated carbonyl group at δC 192.0, and a bicyclic [3.3.1]
nonane-2,4,9-trione moiety16 with three quaternary carbons (δC 69.6, 48.3, and 46.6), one
methane (δC 46.7), one methylene (38.1), a non-conjugated ketone (δC 208.9), and an
enolized 1,3-diketone (δC 194.5, 124.3, and 170.3). [If the enol and ketone interconverted,
two carbon signals would be at ca. δC 194 with one quaternary carbon at ca. δC 119;
however, if an enol ether is present, one carbon signal is shifted upfield to ca. δC 172]. These
data together with the proton NMR data (Table 1) suggested 3 contains a bicyclic [3.3.1]
nonane-2,4,9-trione moiety attached to four prenyl units and a 3,4-disubstituted benzoic acid
moiety. The 1H-1H COSY correlations of H-29/H-30, H-29/H-35, and H-30/H-31 (Figure
1), along with HMBC correlations of H-29/C-4, C-35, C-36, and H-30/C-5, C-32, C-34,
were used to establish a 1-isobutenyl-2-propenyl-tetrahydropyran ring moiety fused at C-4
and C-5 of the nonane system. Based on the 1H and 13C NMR spectra, 3 has a similar
structure to that of isoxanthochymol (8),20 except for the substitution pattern on the
tetrahydropyran ring.
The relative configurations at C-1, C-5, C-7, C-29, and C-30 in 3 were determined on the
basis of the NOESY spectrum (Figure 2b) and coupling constant analysis, while assignment
of the methylene protons at C-6, C-17, C-24 and C-31 as proR or proS relied on NOE data
and the dihedral angular dependence of three bond C-H correlations.21 Like the relative
stereochemistry of isoxanthochymol,20 the correlations of H3-22/H-17proR, H3-22/
H-24proR, H3-23/H-17proS, H3-23/H-6proS, H3-23/H-7, and H-7/H-30, H-30/H-31proR,
indicated that CH2-17, CH3-22, H-7, H-30, and CH2-31 all have an α-orientation. NOESY
correlations between H-29 and H-33, suggested that C-35 and C-32 are anti to each other.
The coupling patterns of H-29 (δH 4.59, t-like, J29,35 = 9.0, Hz J29,30 = 10.0 Hz, in pyridine-
d5), H-30 (δH 2.71, t-like, J29,30 = 10.5 Hz, J30,31S = 13.0 Hz, in pyridine-d5), and H-31proS
(δH 2.59, t, J31proS,31proR = J31proS,30 = 13.5 Hz, in pyridine-d5) further confirmed axial
orientations for H-29, H-30, and H-31proS and equatorial orientations for C-35 and C-31.
Therefore, the structure of garcinialiptone B (3) was determined as shown.
(−)-Cycloxanthochymol (4) was obtained as a yellow solid. The HRESIMS indicated a
molecular formula of C38H50O6 (m/z 625.3545 [M + Na]+). Compound 4 and
cycloxanthochymol (9, isolated from the same plant source in this present investigation)
showed a striking resemblance in their spectroscopic data, indicating a close similarity
between the two molecules. However, like compounds 1 and 2, one main difference between
4 and 9 was their opposite optical rotations. The specific optical rotation [α]25D of
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cycloxanthochymol (9) is +104.0 (c 3.00, MeOH), whereas that of 4 is [α]25D −80.9 (c 2.20,
MeOH). Thus, 4 was concluded to be the enantiomer of cycloxanthochymol, and has been
named (−)-cycloxanthochymol.
The molecular formula of 5, C38H50O7 (corresponding to 14 units of unsaturation), was
established by HRESIMS (m/z 641.3494 [M + Na]+). Analysis of the spectroscopic data
showed 5 to be a polyprenylated benzoylphloroglucinol derivative. Its 1H and 13C NMR
(Table 1, Table 2) spectra showed the presence of a bicyclic [3.3.1] nonane-2,4,9-trione
basic skeleton and a 3,4-dihydroxybenzoyl group. The other pendant residues were assigned
as gem-dimethyl groups (C-17 and C-18), a 2-isopropenyl-5-methylhex-5-enyl group (C-19
to C-28), a prenyl group (C-29 to C-32), and a (2-hydroxy-isopropyl)-dihydrofuran ring
moiety (C-34 to C-38) based on 1D and 2D NMR results. Inspection of the HMBC spectrum
of 5 showed long-range correlations between H2-34/C-2 and C-3, and between H2-29/C-4,
C-5, C-6 and C-9, and thus the (2-hydroxy-isopropyl)-dihydrofuran ring was established at
C-2 and C-3, with the prenyl group connected at C-5. 1H-1H COSY correlations of H-20/
H-19, H-19/H-7, and H-7/H-6 were observed, indicating that the 2-isopropenyl-hex-5-enyl
group was located at C-7. Therefore, the 3,4-dihydroxybenzoyl group must be located at
C-1. In order to determine the relative stereochemistry of 5, a NOESY experiment was
performed. Cross peaks of H3-17/H-19 (δH 2.11) and H-29 (δH 2.15), H3-18/H-7 (δH 1.67),
and H-6 (δH 1.40)/H-19 (δH 2.11) and H-29 were observed, indicating that the CH3-17,
CH2-19, and CH2-29 are all located on the α-face. For benzophenone types A and C,
Grossman et al.17 have clarified the saturated ring conformation (chair or boat) and the C-7
prenyl group orientation (exo or endo), based on NMR chemical shift analysis for the ring
CH2-6 (1H), geminal methyls (13C), and C-7 (13C). With a chair conformation and an exo
C-7 prenyl, the following values are usually found: ΔδH ca. 0.5 ppm (ring CH2-6), ΔδC ca.
7.7 ppm (geminal methyls), and the C-7 chemical shift at ca 43 ppm. In contrast, with a boat
conformation and endo C-7 prenyl, the values would be ΔδH ca. 0.2 ppm (ring CH2-6), ΔδC
ca. 4.0 ppm (geminal methyls), and the C-7 chemical shift at ca 48 ppm. For compound 5,
the diastereotopic ring CH2-6 proton signals resonated 0.48 ppm apart, the diastereotopic
Me groups (Me-17 and Me-18) resonated 8.6 ppm apart, and the C-7 chemical shift was
found at δH 44.2 ppm. Thus, the structure of 5 was deduced to have a chair conformation in
the more saturated ring (C-5, C-6, C-7, C-8, C-1 and C-9). Also, like nemorosone II,17 the 2-
isopropenyl-hex-5-enyl group was linked exo at C-7, and the benzophenone and prenyl units
were located equatorially at C-1 and C-5, respectively. The structure of 5 is closely similar
to that of garcinielliptone FB,12 except for changes at the C-2 and C-4 positions. Thus, the
complete structure of 5 was determined as shown, and this compound has been named
garcinialiptone C.
The molecular formula for 6, C38H50O6, was deduced by HRESIMS (625.3545 [M + Na]+).
The 1H and 13C NMR spectra and molecular formula suggested it to also be a
polyprenylated benzoylphloroglucinol derivative, and to possess the same pendant residues
as 5 at the C-1, C-5, and C-7 positions. Based on the HMBC spectrum, the last substituted
prenyl group was located at C-3, and the planar structure of 6 was established. However, it
still remained to determine the relative positions of the enol and ketone between C-2 and
C-4. Intensive study of 13C NMR literature data for type A benzophenone compounds
showed that these positions can be decided by the ΔδC value between C-1 and C-5. As
shown in Table 3, C-1 and C-5 would resonate 21 ppm apart if the enolized 1,3-diketone is
present as a C-2 ketone and C-4 enol, and in contrast, C-1 and C-5 would differ by only ΔδC
7 ppm with a C-2 enol and C-4 ketone. Consequently, the enolized 1,3-diketone in 6 is
present as a 2-ketone and 4-enol, because the actual ΔδC value of 15.3 ppm is closer to ΔδC
21 ppm. The relative configuration of 6 was confirmed as described for 5; accordingly, the
structure of 6 was assigned unambiguously as shown.
Zhang et al. Page 4













Moreover, the three known compounds, xanthochymol (7),27 isoxanthochymol (8),20 and
cycloxanthochymol (9),27 also isolated were confirmed by comparing their NMR and MS
data with analytical data reported in the literature.
All isolates (1-9) and garsubellin A (10, isolated by Lin and coworkers from the seeds of G.
subelliptica)9 were evaluated for anticancer activity against human tumor cell lines,
including non-small lung carcinoma (A549), prostate carcinoma (DU145), and
nasopharyngeal carcinoma (KB). Also used were vincristine-resistant KB (KBvin) cells,
which exhibit the multi-drug resistant (MDR) phenotype associated with P-glycoprotein
overexpression. The potent antitumor drug paclitaxel was used as a positive control.
Cytotoxicity data (Table 4) showed that all the polyisoprenyl benzophenonoid compounds
(1-9) had significant but borderline activity (IC50 4–5 µg/mL range); whereas, the
polyprenylated acylphloroglucinol derivative, garsubellin A (10), was inactive (IC50 >5 µg/
mL). Although the new compounds were about 2000-fold less active than paclitaxel, in
contrast to the positive control, all were equally active against the MDR sub-line (KBvin)
suggesting they can by-pass a clinically important P-glycoprotein mechanism of cancer drug
resistance. The results were also consistent with literature reports for the bioactivities of
garcinielliptone FB,12 garcinielliptones A, B, and garsubellin A.9 The current results
suggest that the benzoyl group in the phloroglucinol skeleton played a crucial role for the in
vitro activity that was observed.
Experimental Section
General Experimental procedures
Melting points were determined using a Fisher-Johns melting point apparatus and are
uncorrected. Optical rotations were obtained on a JASCO P-1020 polarimeter. UV spectra
were measured with a GBC 918 spectrophotometer. IR spectra were recorded as KBr disks,
using an IR-FT Mattson Genesis II spectrometer. NMR spectra were recorded using Bruker
UltraShield 400 MHz and Varian Inova-500 MHz spectrometers. High resolution ESIMS
were determined using a Finingan MAT 95S mass spectrometer. For column
chromatography, silica gel 60 (70 – 230, 230 – 400 mesh, Merck), and Sephadex LH-20
(Pharmacia) were used. Precoated silica gel (Merck 60 F-254) plates were used for TLC.
The spots on TLC were detected by spraying with 5% H2SO4 and then heating at 110 °C.
MPLC was performed on a system equipped with a Buchi pump B-688, Buchi B-684
fraction collector and Buchi columns. HPLC separations were performed on a Shimadzu
LC-8A series apparatus with a SPD-20A UV detector, equipped with a 250 × 20 mm i.d.
preparative Cosmosil 5C18 AR-II column (Nacalai Tesque, Inc.).
Plant Material
The fruits of G. subelliptica were collected in the northern mountains of Taiwan, in June
2005 and June 2007 and identified by one of us (Y.H. Kuo). A voucher specimen (no.
NRICM20070614A) has been deposited in the National Research Institute of Chinese
Medicine, Taipei, Taiwan.
Extraction and Isolation
The pericarp of G. subelliptica (12.5 kg dried; obtained in 2007) was extracted three times
with acetone at 45 °C. The acetone extract was concentrated under reduced pressure, and the
residue (1.53 kg) was coated on 1.3 kg silica gel, and separated by passage over MPLC
silica gel column eluting with n-hexane/CHCl3/acetone (1:0:0, 2:1:0, 1:2:0, 0:1:0, 0:10:1,
0:3:1, 0:1:1, 0:0:1) to yield eight fractions (Fr 1 to Fr 8). Fraction 4 (CHCl3/acetone, 1:2, 25
g) was then submitted to Sephadex LH-20 CC eluting with CHCl3/MeOH/acetone (1:1:1), to
afford four fractions (Fr 4.1 to Fr 4.4). Fr 4.2 (20 g) was subjected to silica gel MPLC
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column eluting with n-hexane/CHCl3/acetone from 1:0:0 to 5:5:2, to give eight fractions (Fr
4.2.1 to Fr 4.2.8). In turn, Fr 4.2.2 was subjected to Sephadex LH-20 CC eluting with
CHCl3/MeOH (1:1) to give six fractions (Fr 4.2.2.1 to Fr 4.2.2.6). Fr 4.2.2.4 (4.80 g) was
subjected to reverse phase HPLC ODS column eluting with 90% MeCN (10 mL/min,
Cosmosil 250 × 20 mm i.d.) to afford six fractions (Fr 4.2.2.4.1 to Fr 4.2.2.4.6). Fr 4.2.2.4.3
was purified repeatedly by recycle preparative HPLC (250 × 20 mm i.d., Cosmosil 5C18
AR-II column, MeCN:H2O, 80:20, repeated for five times) to afford compound 3 (54.1 mg).
Fr 4.2.2.4.4 and Fr 4.2.2.4.5 were purified by the same method to afford compounds 2 (62.6
mg), 4 (22.4 mg), 5 (60.1 mg), 8 (49.6 mg), and 9 (12.0 mg). Fraction 5 (CHCl3 100%, 8.0
g) was chromatographed by repeated silica gel, LH-20, and recycle HPLC to afford
compound 6 (66.2 mg).
The pericarp of G. subelliptica (5.5 kg dried, collected in 2005) was extracted three times
with 95% EtOH at 50 °C. The EtOH extract was concentrated under reduced pressure, and
the residue (400 gm) was suspended in water, and this suspension was successively
extracted with n-hexane, EtOAc, and n-BuOH. The EtOAc layer provided 80 gm extract and
was separated using a MPLC silica gel column eluting with n-hexane/CHCl3/MeOH (1:0:0,
2:1:0, 1:2:0, 0:1:0, 0:20:1, 0:10:1, 0:5:1, 0:0:1), to yield 13 fractions (Fr E1 to Fr E13).
Fraction E6 (CHCl3 100%, 5.8 gm) was then submitted to Sephadex LH-20 CC eluting with
CHCl3/MeOH/acetone (2:1:1), to afford five fractions (Fr E6.1 to Fr E6.5). Fr E6.3 (3.3 gm)
was subjected to passage over a silica gel MPLC column eluting with CHCl3/acetone/MeOH
from 1:0:0 to 9:1:1, to give seven subfractions (Fr E6.3.1 to Fr E6.3.7). Fr E6.3.1 (1.1 g) was
separated using a ODS MPLC column (Vercopak, C18, cartridge, 40 × 150 mm i.d.) eluting
with MeCN/H2O 70:30, to give six fractions (Fr E6.3.1.1 to Fr E6.3.1.6). Fr E6.3.1.4 (90
mg) was purified using a LH-20 open column, eluting with pure MeOH, to afford compound
1 (69.7 mg). Fr E6.3.1.6 was purified also using a LH-20 open column eluting with pure
MeOH to afford compound 7 (150 mg).
(+)-Garcinialiptone A (1)
Yellow solid, mp 106 °C; [α]25D +12.1 (c 3.40, MeOH); UV (MeOH) λmax (log ε) 314
(3.84), 280 (3.91), and 232 (sh, 4.16) nm; IR νmax (KBr) 3403, 3074, 2970, 2927, 1742,
1700, 1599, 1549, 1518, 1440, 1289, 763 cm−1; 1H NMR and 13C NMR data are shown in
Table 1 and Table 2; HRESIMS m/z 623.3377 [M + Na]+ (Calcd for C38H48O6Na:
623.3349).
(−)-Garcinialiptone A (2)
Yellow solid, mp 109 °C; [α]25D −17.3 (c 3.36, MeOH); UV (MeOH) λmax (log ε) 313
(3.85), 279 (3.94), and 231 (4.20) nm; IR νmax (KBr) 3400, 3073, 2970, 2923, 1739, 1695,
1592, 1552, 1521, 1438, 1291, 756 cm−1; 1H NMR and 13C NMR data are shown in Table 1
and Table 2; HRESIMS m/z 623.3391 [M + Na]+ (Calcd for C38H48O6Na: 623.3349).
Garcinialiptone B (3)
Yellow solid, mp 111 °C (dec.); [α]25D +84.8 (c 5.40, MeOH); UV (MeOH) λmax (log ε)
313 (3.84), 276 (4.13), and 229 (4.19) nm; IR νmax (KBr) 3344, 3082, 2973, 2934, 1727,
1668, 1645, 1598, 1555, 1516, 1445, 1297, 758 cm−1; 1H NMR and 13C NMR data are
shown in Table 1 and Table 2; HRESIMS m/z 623.3386 [M + Na]+ (Calcd for C38H48O6Na:
623.3349).
(−)-Cycloxanthochymol (4)
Yellow solid, mp 225 °C; [α]25D −80.9 (c 2.20, MeOH); UV (MeOH) λmax (log ε) 313
(3.97), 277 (4.23), and 230 (4.29) nm; IR νmax (KBr) 3400, 2975, 2927, 1728, 1666, 1592,
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1522, 1441, 1287, 760 cm−1; 1H NMR and 13C NMR data are shown in Table 1 and Table
2; HRESIMS m/z 625.3545 [M + Na]+ (Calcd for C38H50O6Na: 625.3505).
Garcinialiptone C (5)
Yellow solid, mp 209 °C; [α]25D −94.0 (c 0.86, MeOH); UV (MeOH) λmax (log ε) 320 (sh,
3.88), 284 (4.20), and 235 (sh, 4.20) nm; IR νmax (KBr) 3400, 3068, 2976, 2930, 1724,
1686, 1600, 1594, 1524, 1443, 1278, 758 cm−1; 1H NMR and 13C NMR data are shown in
Table 1 and Table 2; HRESIMS m/z 641.3494 [M + Na]+ (Calcd for C38H50O7Na:
641.3454);.
Garcinialiptone D (6)
Yellowish solid, mp 118 °C; [α]25D −79.1 (c 7.83, MeOH); UV (MeOH) λmax (log ε) 313
(3.84), 280 (4.23), and 232 (4.21) nm; IR νmax (KBr) 3300, 3067, 2968, 2930, 1723, 1688,
1630, 1597, 1516, 1440, 1291, 756 cm−1; 1H NMR and 13C NMR data are shown in Table 1
and Table 2; HRESIMS m/z 625.3545 [M + Na]+ (Calcd for C38H50O6Na: 625.3505).
Cytotoxicity Assay
All stock cultures were grown in T-25 flasks. Freshly trypsinized cell suspensions were
seeded in 96-well microtiter plates at densities of 1500–7500 cells per well with compounds
added from DMSO-diluted stock. After 3 days in culture, attached cells were fixed with cold
50% trichloroacetic acid and then stained with 0.4% sulforhodamine B (SRB). The
absorbency at 562 nm was measured using a microplate reader after solubilizing the bound
dye. The mean IC50 is the concentration of agent that reduces cell growth by 50% under the
experimental conditions and is the average from at least three independent determinations
that were reproducible and statistically significant. The following human tumor cell lines
were used in the assay: A549 (human lung carcinoma), DU145 (prostate cancer), KB
(nasopharyngeal carcinoma), and KB-vin (vincristine-resistant KB subline). All cell lines
were obtained from Lineberger Cancer Center (UNC-CH) or from ATCC (Rockville, MD),
except KB-vin, which was a generous gift of Professor Y.-C. Cheng, Yale University. Cells
were cultured in RPMI-1640 medium supplemented with 25mM HEPES, 0.25% sodium
bicarbonate, 10% fetal bovine serum, and 100 µg/mL kanamycin.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key HMBC (→) and COSY (▬) correlations of compounds 1 and 5
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Key HMBC (→ a), COSY (▬ a) and NOE (b) correlations of 3
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Table 4
Cytotoxicity Data of 1-9 against Four Human Tumor Cells
cell line (IC50, µg/mL)a
compound A549b DU145b KBb KBvinb
1 4.2 4.1 5.7 5.6
2 4.2 4.2 4.4 5.3
3 6.7 7.3 5.7 6.6
4 4.5 4.7 4.9 5.2
5 4.3 4.3 3.4 4.9
6 4.4 3.3 3.9 4.6
7 4.0 4.0 5.0 4.6
8 4.4 4.2 4.5 5.2
9 4.5 3.7 5.0 4.9
paclitaxel 0.002 0.002 0.002 >0.085
a
IC50 = concentration that causes a 50% reduction in absorbance at 562 nm relative to untreated cells using the SRB assay.
b
The cell lines are described in the Experimental Section.
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